Atlanta’s nonprofit Countdown is stepping into the spotlight with a mission to accelerate research on mitochondria – the tiny powerhouses inside every cell that convert nutrients into energy. Founder and President Mitzi Solomon launched the organization after a lifetime of personal health challenges and a family history of a rare primary mitochondrial disease.
Why mitochondria matter
Mitochondria regulate metabolism, immune responses and cellular communication. When they malfunction, energy‑demanding organs such as the brain, heart and muscles can suffer. Primary mitochondrial diseases stem from genetic defects that directly impair mitochondrial function, while secondary dysfunction can arise from aging, other illnesses or environmental factors.
Research funding and early results
Since its inception, Countdown reports raising more than $3.5 million and directing over $2.2 million toward research in the past three years. The nonprofit backs high‑risk, high‑reward projects that traditional funders often overlook. Current initiatives include:
- Development of blood‑based biomarkers with Minovia Therapeutics to assess mitochondrial health.
- Experimental mitochondrial transplantation research led by James D. McCully at Harvard Medical School and Boston Children’s Hospital, exploring whether healthy mitochondria can preserve muscle function in Duchenne muscular dystrophy.
While these studies are still in early stages, they illustrate the potential for mitochondrial science to impact a wide range of conditions, from Alzheimer’s and Parkinson’s disease to autism and cerebral palsy.
Community impact and future goals
Countdown’s CEO Julie Teer, former president of the Wellstar Foundation, emphasizes that less than 1 % of philanthropic research funding has historically gone to mitochondrial science. She hopes to change that through partnerships, fundraising and public education.
Both Solomon and Teer stress everyday habits that support cellular health – regular exercise, balanced nutrition, stress management and adequate sleep. Their upcoming “Evening of Energy” gala on Jan. 30, 2027, will bring together scientists, business leaders and philanthropists to further the cause.
Atlanta’s emerging role
Teer envisions Countdown helping Atlanta become a national hub for mitochondrial research, attracting talent and investment to the region. By fostering collaboration among local universities, hospitals and biotech firms, the nonprofit aims to create jobs and position the city at the forefront of a promising scientific frontier.
For families waiting for answers, the message is clear: every moment counts, and advances in mitochondrial science could one day translate into earlier detection, better prevention and more effective treatments for countless health challenges.
Original reporting: SaportaReport — read the source article.